For the first quarter (Q1 FY27), Fortis delivered a strong top-line performance with consolidated revenue jumping 17.4% year-on-year to ₹2,545 crore, propelled by steady demand across hospital services and a recovering diagnostics arm.
For the first quarter (Q1 FY27), Fortis delivered a strong top-line performance with consolidated revenue jumping 17.4% year-on-year to ₹2,545 crore, propelled by steady demand across hospital services and a recovering diagnostics arm.
<iframe src="https://hindustansphere.com/embed/cluster/ba4f545cf08bb3fc029b7433cf6cf73d7edc5419" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Fortis Healthcare Q1 Review: Analysts Bullish Despite Short-Term Margin Pressure — Should You Buy?"></iframe>
